Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
27.00
+0.33 (1.24%)
At close: Apr 24, 2026, 4:00 PM EDT
27.11
+0.11 (0.41%)
Pre-market: Apr 27, 2026, 6:35 AM EDT
Pfizer Employees
Pfizer had 75,000 employees as of December 31, 2025. The number of employees decreased by 6,000 or -7.41% compared to the previous year.
Employees
75,000
Change (1Y)
-6,000
Growth (1Y)
-7.41%
Revenue / Employee
$834,387
Profits / Employee
$103,613
Market Cap
153.59B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75,000 | -6,000 | -7.41% |
| Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
| Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
| Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
| Dec 31, 2021 | 79,000 | 500 | 0.64% |
| Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
| Dec 31, 2019 | 88,300 | -4,100 | -4.44% |
| Dec 31, 2018 | 92,400 | 2,200 | 2.44% |
| Dec 31, 2017 | 90,200 | -6,300 | -6.53% |
| Dec 31, 2016 | 96,500 | -1,400 | -1.43% |
| Dec 31, 2015 | 97,900 | 19,600 | 25.03% |
| Dec 31, 2014 | 78,300 | 600 | 0.77% |
| Dec 31, 2013 | 77,700 | -13,800 | -15.08% |
| Dec 31, 2012 | 91,500 | -12,200 | -11.76% |
| Dec 31, 2011 | 103,700 | -6,900 | -6.24% |
| Dec 31, 2010 | 110,600 | -5,900 | -5.06% |
| Dec 31, 2009 | 116,500 | 34,700 | 42.42% |
| Dec 31, 2008 | 81,800 | -4,800 | -5.54% |
| Dec 31, 2007 | 86,600 | -11,400 | -11.63% |
| Dec 31, 2006 | 98,000 | -8,000 | -7.55% |
| Dec 31, 2005 | 106,000 | -9,000 | -7.83% |
| Dec 31, 2004 | 115,000 | -7,000 | -5.74% |
| Dec 31, 2003 | 122,000 | 24,000 | 24.49% |
| Dec 31, 2002 | 98,000 | 8,000 | 8.89% |
| Dec 31, 2001 | 90,000 | 0 | - |
| Dec 31, 2000 | 90,000 | 39,100 | 76.82% |
| Dec 31, 1999 | 50,900 | 4,500 | 9.70% |
| Dec 31, 1998 | 46,400 | -2,800 | -5.69% |
| Dec 31, 1997 | 49,200 | 2,700 | 5.81% |
| Dec 31, 1996 | 46,500 | 2,700 | 6.16% |
| Dec 31, 1995 | 43,800 | 3,000 | 7.35% |
| Dec 31, 1994 | 40,800 | 300 | 0.74% |
| Dec 31, 1993 | 40,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| AbbVie | 57,000 |
PFE News
- 2 days ago - Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy - Reuters
- 3 days ago - Pfizer Transcript: AGM 2026 - Transcripts
- 4 days ago - Pfizer Declares Second-Quarter 2026 Dividend - Business Wire
- 5 days ago - Pfizer GLP-1 weight loss drug available for pre-order in China - Reuters
- 5 days ago - Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 - Business Wire
- 6 days ago - Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says - Reuters
- 6 days ago - U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility - PRNewsWire
- 16 days ago - Big Pharma Is Turning to China for the Newest Drug Ideas - WSJ